Neurotoxicity of the anticoagulant-selective E149A-activated protein C variant after focal ischemic stroke in mice.
about
Cytoprotective-selective activated protein C therapy for ischaemic strokeEffects of exogenous recombinant APC in mouse models of ischemia reperfusion injury and of atherosclerosis.Thrombin mutant W215A/E217A treatment improves neurological outcome and attenuates central nervous system damage in experimental autoimmune encephalomyelitis.Activated protein C promotes neuroprotection: mechanisms and translation to the clinic.2016 Scientific Sessions Sol Sherry Distinguished Lecturer in Thrombosis: Thrombotic Stroke: Neuroprotective Therapy by Recombinant-Activated Protein C.Can adjunctive therapies augment the efficacy of endovascular thrombolysis? A potential role for activated protein C.
P2860
Neurotoxicity of the anticoagulant-selective E149A-activated protein C variant after focal ischemic stroke in mice.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Neurotoxicity of the anticoagu ...... focal ischemic stroke in mice.
@en
Neurotoxicity of the anticoagu ...... focal ischemic stroke in mice.
@nl
type
label
Neurotoxicity of the anticoagu ...... focal ischemic stroke in mice.
@en
Neurotoxicity of the anticoagu ...... focal ischemic stroke in mice.
@nl
prefLabel
Neurotoxicity of the anticoagu ...... focal ischemic stroke in mice.
@en
Neurotoxicity of the anticoagu ...... focal ischemic stroke in mice.
@nl
P2093
P2860
P1476
Neurotoxicity of the anticoagu ...... focal ischemic stroke in mice.
@en
P2093
Berislav V Zlokovic
John H Griffin
Laurent O Mosnier
Ranjeet Kumar Sinha
Yaoming Wang
P2860
P304
P356
10.1016/J.BCMD.2013.02.009
P577
2013-03-29T00:00:00Z